Dana-Farber Cancer Institute at St. Elizabeths Medical Center — Brighton, Massachusetts

Dana-Farber Cancer Institute at St. Elizabeths Medical Center is a clinical research site located in Brighton, Massachusetts, United States 02135.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at St. Elizabeths Medical Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at St. Elizabeths Medical Center?

Dana-Farber Cancer Institute at St. Elizabeths Medical Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at St. Elizabeths Medical Center conducted?

Dana-Farber Cancer Institute at St. Elizabeths Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Is Dana-Farber Cancer Institute at St. Elizabeths Medical Center accredited by Crixeo Health?

Dana-Farber Cancer Institute at St. Elizabeths Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute at St. Elizabeths Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.